| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2590* | 2021 |
| International incidence of childhood cancer, 2001–10: a population-based registry study E Steliarova-Foucher, M Colombet, LAG Ries, F Moreno, A Dolya, F Bray, ... The lancet oncology 18 (6), 719-731, 2017 | 2404 | 2017 |
| Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ... The lancet oncology 21 (2), 271-282, 2020 | 1920 | 2020 |
| Integrase inhibitors to treat HIV/AIDS Y Pommier, AA Johnson, C Marchand Nature reviews Drug discovery 4 (3), 236-248, 2005 | 1028 | 2005 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 995* | 2022 |
| Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications P Yilmaz, R Kottmann, D Field, R Knight, JR Cole, L Amaral-Zettler, ... Nature biotechnology 29 (5), 415-420, 2011 | 840 | 2011 |
| Natural gas hydrates: A review TS Collett, AH Johnson, CC Knapp, R Boswell | 585 | 2009 |
| UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation UK Collaborative ECMO Trial Group The Lancet 348 (9020), 75-82, 1996 | 584 | 1996 |
| Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ... The Lancet Oncology 21 (2), 261-270, 2020 | 561 | 2020 |
| A broadly implementable research course in phage discovery and genomics for first-year undergraduate students TC Jordan, SH Burnett, S Carson, SM Caruso, K Clase, RJ DeJong, ... MBio 5 (1), 10.1128/mbio. 01051-13, 2014 | 528 | 2014 |
| Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase AA Johnson, AS Ray, J Hanes, Z Suo, JM Colacino, KS Anderson, ... Journal of Biological Chemistry 276 (44), 40847-40857, 2001 | 498 | 2001 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 424* | 2022 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 328 | 2019 |
| Prophage-mediated defence against viral attack and viral counter-defence RM Dedrick, D Jacobs-Sera, CAG Bustamante, RA Garlena, TN Mavrich, ... Nature microbiology 2 (3), 1-13, 2017 | 300 | 2017 |
| Financial account up-front incentives management system and method A Johnson, R Riddett US Patent App. 10/891,410, 2005 | 257 | 2005 |
| Scanning tunnelling microscopy of charge-density waves in transition metal chalcogenides RV Coleman, B Giambattista, PK Hansma, A Johnson, WW McNairy, ... Advances in Physics 37 (6), 559-644, 1988 | 251 | 1988 |
| Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial LC Chappell, P Brocklehurst, ME Green, R Hunter, P Hardy, E Juszczak, ... The Lancet 394 (10204), 1181-1190, 2019 | 249 | 2019 |
| Learning health systems using data to drive healthcare improvement and impact: a systematic review J Enticott, A Johnson, H Teede BMC health services research 21 (1), 200, 2021 | 215 | 2021 |
| brms: Bayesian regression models using Stan PC Bürkner, J Gabry, S Weber, A Johnson, M Modrak, HS Badr, F Weber, ... R package version 1 (0), 2016 | 213 | 2016 |
| Exonuclease proofreading by human mitochondrial DNA polymerase AA Johnson, KA Johnson Journal of Biological Chemistry 276 (41), 38097-38107, 2001 | 206 | 2001 |
